• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. VERSA SPRING TIP; HYSTEROSCOPE (AND ACCESSORIES)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. VERSA SPRING TIP; HYSTEROSCOPE (AND ACCESSORIES) Back to Search Results
Catalog Number 00468
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Embolism (1829)
Event Type  Injury  
Manufacturer Narrative
Product complaint #: (b)(4).This report is related to a journal article, therefore no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.Authors : david c.Hunter, david w.Cooper and graham phillips.Citation: gynaecological endoscopy 2001; 10, 261-264.(b)(4).
 
Event Description
It was reported in a journal article entitled : gas embolism during versapoint hysteroscopic myomectomy.This is a case report concerning a 40-year-old woman with menorrhagia secondary to uterine fibroids.During the procedure, the patient was placed in the lithotomy position with slight head-down tilt (5-10°), and the cervix was dilated with very little resistance to bonney parker size 8.A baggish 8-mm three-channel operating hysteroscope was inserted through the cervix into the uterine cavity.Saline was insufflated through a hys-surgimat hysteroflator set at 250 ml min-1 and initial pressure of 75 mmhg.To reduce fluid absorption the maximum insufflation pressure was adjusted according to the mean arterial pressure.Further, hysteroscopic versapoint spring (ethicon) endometrial ablation and submucous myomectomy were under general anaesthetic with saline as the distension medium.Intraoperatively an acute and profound drop in the patient's end-tidal carbon dioxide and oxygen saturation suggested of gas embolism, the procedure was then abandoned which the patient was treated with 100% oxygen.The patient was then transferred to the recovery ward for 90 min.She remained stable with an oxygen saturation of >97% on 5 l of oxygen via a facemask, with a normal heart rate and blood pressure.After several hours of observation on the gynaecology ward she was discharged later the same day.It was reported by the authors that there are three factors which may have contributed to the gas embolism: (a) head-down tilt with a patulous cervix; (b) versapoint vaporization, and (c) air within the fluid insufflation set.In conclusion, it is suggested that further evaluation of versapoint is required, and that this case highlights the need for vigilance when preparing for and performing hysteroscopic surgery.
 
Manufacturer Narrative
Product complaint#: (b)(4).Additional information: medwatch#: 2210968-2019-88512 was initially sent on 10/9/2019 and reached ack2 on 10/9/2019.Intermittent failure occurred at the cdrh system between 10/09 and 10/10.On 10/18/2019 we received an error message: there is a duplicate report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSA SPRING TIP
Type of Device
HYSTEROSCOPE (AND ACCESSORIES)
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
MDR Report Key9210102
MDR Text Key167436325
Report Number2210968-2019-88837
Device Sequence Number1
Product Code HIH
UDI-Device Identifier10705031000797
UDI-Public10705031000797
Combination Product (y/n)N
PMA/PMN Number
K040302
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,literature
Type of Report Initial,Followup
Report Date 09/16/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/18/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Device Catalogue Number00468
Was Device Available for Evaluation? No
Date Manufacturer Received09/16/2019
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-